Texas Oncology - Central South, Austin
University of Texas Southwestern Medical Center/Clinical Research Department, Dallas
Texas Oncology - West Texas, Odessa

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/14更新 · NCT07218146

A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy

MD Anderson Cancer Center, Houston

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/11更新 · NCT07564401

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

Texas Oncology - Central/South Texas, Austin
Texas Oncology - Northeast Texas, Tyler

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/11更新 · NCT06646276

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Dallas
Avenzo Therapeutics Recruiting Site, Houston
Avenzo Therapeutics Recruiting Site, San Antonio

被験者募集中第1/2相

18歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07038343

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

The University of Texas MD Anderson Cancer Center, Houston
Texas Oncology Cancer Center, Sugar Land

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/01更新 · NCT06712355

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

MD Anderson Cancer Center Uni of Te, Houston

被験者募集中第1/2相

18歳〜100歳 · 全性別 · 2026/08/27更新 · NCT06726148

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Texas Oncology - DFW, Dallas
MD Anderson Cancer Center, Houston
Texas Oncology - Northeast, Tyler

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/26更新 · NCT06892548

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

UT Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston

被験者募集中第1相

18歳以上 · 全性別 · 2026/08/25更新 · NCT07488923

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
University of Texas Southwestern Medical Center, Dallas

被験者募集中第2相

18歳以上 · 全性別 · 2026/08/17更新 · NCT06095505

A Study of MGC026 in Participants With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
University of Texas Health Science Center at Houston, Houston

被験者募集中第1相

18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

The University of Texas, MD Anderson Cancer Center, Houston
UT Health Mays Cancer Center, San Antonio

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Houston Methodist Cancer Center, Houston
University of Texas Md Anderson Cancer Center, Houston
Texas Oncology, P.A. - Tyler, Tyler

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/06更新 · NCT06203210

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, San Antonio

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/06更新 · NCT07749586

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
NEXT Dallas, Irving
South Texas Accelerated Research Therapeutics, LLC, San Antonio

被験者募集中第1相

18歳以上 · 全性別 · 2026/07/22更新 · NCT06131840

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Mays Cancer Center / University of Texas, San Antonio, San Antonio

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/07/15更新 · NCT05652686

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

The University of Texas MD Anderson Cancer Center, Houston
Oncology Consultants, PA- Houston, Houston
Next Oncology Dallas, Irving

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/07/09更新 · NCT07174583

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

University of Texas MD Anderson Cancer Center, Houston

被験者募集中第1相

18歳以上 · 全性別 · 2026/06/26更新 · NCT06598306

A Study of LY4175408 in Participants With Advanced Cancer

MD Anderson Cancer Center, Houston

被験者募集中第1相

18歳以上 · 全性別 · 2026/06/23更新 · NCT07046923

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

START Dallas, Fort Worth

被験者募集中第1相

18歳以上 · 全性別 · 2026/06/10更新 · NCT07517198

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

NEXT Oncology, Irving

被験者募集中第1相

18歳以上 · 全性別 · 2026/06/02更新 · NCT07454642

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

NEXT Oncology Austin, Austin
NEXT Oncology San Antonio, San Antonio

被験者募集中第1相

18歳以上 · 全性別 · 2026/04/07更新 · NCT07424547

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

M D Anderson Cancer Center, Houston

被験者募集中第2相

18歳以上 · 全性別 · 2026/03/30更新 · NCT06769126

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/03/11更新 · NCT06681220

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

NEXT Oncology - Dallas, Dallas
START San Antonio, San Antonio

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/02/18更新 · NCT07030257

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

Mary Crowley Cancer Research, Dallas

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/01/09更新 · NCT05490472

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

The University of Texas MD Anderson Cancer Center (site 127), Houston

被験者募集中第1/2相

18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 135, Austin
Research Site 120, Dallas

被験者募集中第1/2相

18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

The University of Texas MD Anderson Cancer Center, Houston

被験者募集中第1相

18歳以上 · 全性別 · 2025/09/23更新 · NCT06805825

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。